UBS Group’s ASP Isotopes ASPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.6M Buy
2,841,709
+435,252
+18% +$2.57M ﹤0.01% 3107
2025
Q4
$12.9M Buy
2,406,457
+1,445,165
+150% +$11.5M ﹤0.01% 3030
2025
Q3
$9.25M Sell
961,292
-466,984
-33% -$4.31M ﹤0.01% 3383
2025
Q2
$10.5M Buy
1,428,276
+412,812
+41% +$2.77M ﹤0.01% 3038
2025
Q1
$4.76M Sell
1,015,464
-939,433
-48% -$4.69M ﹤0.01% 3821
2024
Q4
$8.86M Buy
1,954,897
+1,891,178
+2,968% +$10.1M ﹤0.01% 3200
2024
Q3
$177K Buy
63,719
+11,729
+23% +$31.2K ﹤0.01% 5963
2024
Q2
$159K Buy
+51,990
New +$201K ﹤0.01% 5823
2024
Q1
Sell
-3,277
Closed -$5.87K 9278
2023
Q4
$5.87K Sell
3,277
-1,265
-28% -$1.85K ﹤0.01% 7750
2023
Q3
$4.32K Buy
+4,542
New +$4.68K ﹤0.01% 7452
2023
Q2
Sell
-2,091
Closed -$1.79K 8886
2023
Q1
$1.79K Buy
2,091
+303
+17% +$475 ﹤0.01% 8644
2022
Q4
$2.83K Buy
+1,788
New +$3.52K ﹤0.01% 9618

Other funds holding ASPI

UBS Group's ASPI Position: Q1 2026 in Review

UBS Group increased its ASP Isotopes (ASPI) stake by 18% in Q1 2026, buying an estimated $2.57M and bringing the position to 2,841,709 shares worth $12.6M. The position accounts for ﹤0.01% of the portfolio, ranked #3107.

UBS Group first reported a position in ASPI in Q4 2022 and has held it in 12 quarters since. The position peaked at $12.9M in Q4 2025. 177 funds tracked by Wall St. Rank hold ASPI as of Q1 2026.

  • UBS Group held 2,841,709 shares of ASP Isotopes worth $12.6M as of Q1 2026.
  • UBS Group bought 435,252 ASP Isotopes shares in Q1 2026, an estimated $2.57M.
  • ASP Isotopes made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3107 holding.
  • UBS Group first reported a position in ASP Isotopes in Q4 2022 and has held it in 12 quarters since.
  • UBS Group's ASP Isotopes position peaked at $12.9M in Q4 2025.
  • 177 funds tracked by Wall St. Rank held ASP Isotopes as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.